@article{article, title  = {{Pharmacokinetics (PK) and pharmacodynamics (PD) of AMG 162, a fully human monoclonal antibody to Receptor Activator of NF kappa B Ligand (RANKL), following a single subcutaneous dose to patients with cancer-related bone lesions}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 year = {{2004}},

 month = {{7}},

 author = {{Peterson MC and Martin SW and Stouch B and Chen D and Holloway DL and Body J-J and Lipton A and Coleman R and Bekker PJ}},

 doi = {{10.1200/jco.2004.22.14_suppl.8106}},

 volume = {{22}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{14_suppl}},

 pages = {{8106-8106}},

 note = {{Accessed on 2026/10/23}}}